Cancer risk in patients with rheumatoid arthritis treated with janus kinase inhibitors: a nationwide Danish register-based cohort study.

MLA

Westermann, Rasmus, et al. “Cancer Risk in Patients with Rheumatoid Arthritis Treated with Janus Kinase Inhibitors: A Nationwide Danish Register-Based Cohort Study.” Rheumatology, vol. 63, no. 1, Jan. 2024, pp. 93–102. EBSCOhost, https://doi.org/10.1093/rheumatology/kead163.

APA

Westermann, R., Cordtz, R. L., Duch, K., Mellemkjaer, L., Hetland, M. L., Burden, A. M., & Dreyer, L. (2024). Cancer risk in patients with rheumatoid arthritis treated with janus kinase inhibitors: a nationwide Danish register-based cohort study. Rheumatology, 63(1), 93–102. https://doi.org/10.1093/rheumatology/kead163

Chicago

Westermann, Rasmus, René Lindholm Cordtz, Kirsten Duch, Lene Mellemkjaer, Merete Lund Hetland, Andrea Michelle Burden, and Lene Dreyer. 2024. “Cancer Risk in Patients with Rheumatoid Arthritis Treated with Janus Kinase Inhibitors: A Nationwide Danish Register-Based Cohort Study.” Rheumatology 63 (1): 93–102. doi:10.1093/rheumatology/kead163.